Dr. Brad Steven Kahl, MD

  • Saint Louis, MO
  • Medical oncologist
NPI1407822430PAC ID3779613757
Medicare services, 2024
3,395
Medicare patients, 2024
456
Part D claims, 2024
904
Publications
250
Clinical trials
18
Practice address
One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110
Practice phone
Call (314) 747-3000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Barnes-Jewish Hospital

Hospital · Saint Louis, Missouri

See all 7 affiliations

Find Dr. Kahl's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Brad Steven Kahl is a medical oncologist in Saint Louis, Missouri

Dr. Kahl practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Kahl's NPI, 1407822430, was assigned on February 28, 2006. Dr. Kahl graduated from Tufts University School Of Medicine in 1994. Dr. Kahl holds Missouri license 2015029481.

NPI and contact details
Medicare PAC ID
3779613757
NPI enumeration date
February 28, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(314) 747-3000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
58
Medical school graduation
1994

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Brad Steven Kahl practices at 2 locations in Saint Louis, Missouri

Dr. Kahl's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Kahl also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

  • Barnes-Jewish HospitalPrimary
    One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 · St. Louis CityPhone(314) 747-3000
  • Barnes-Jewish Hospital
    1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 · Saint Louis CityPhone(314) 747-3000

Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data

Dr. Brad Steven Kahl is affiliated with 6 sites of care and 1 medical group

Dr. Kahl's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Kahl is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Kahl to 3 more hospitals and 1 group practice or clinic, each named with a free account.

See all 7 affiliations for Dr. Kahl

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Brad Steven Kahl's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kahl practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Barnes-Jewish HospitalAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Kahl practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across BJC Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Brad Steven Kahl is one of 120 medical oncologists in Missouri

Medical oncology is Dr. Kahl's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kahl is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kahl's licenses on file in 3 states: Missouri, Illinois and Wisconsin.

Specialties and state licenses

  • Medical oncology, MissouriPrimaryLicense 2015029481 · 2015 to 2026 · taxonomy 207RX0202X
  • Illinois license2020 to 2023
  • Wisconsin license1995 to 2015

Clinical focus

Dmand AI lists chronic leukemia, immune deficiency disease, lung cancer, lymphoma, multiple myeloma, neutropenia and prostate cancer among the conditions Dr. Kahl treats.

Medical oncologists near Dr. Kahl

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Brad Steven Kahl billed Medicare for 3,395 services in 2024

CMS data shows 3,395 Medicare services from Dr. Kahl across 23 procedure codes in 2024, for 456 Medicare patients. Medicare paid $124,765 for them.

Medicare services, 20243,395
Medicare patients456
Paid by Medicare$124,765
Procedure codes23

Dr. Kahl's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 15,5332024: 1,94387%
Office and hospital visits
2023: 8272024: 8847%
Tests and treatments
2023: 7972024: 42846%
Surgery
2023: 3142024: 14055%
Other services
2023: 212024: 0100%

Where Dr. Kahl's Medicare services took place, 2024

  • In an office2,98888%
  • In a facility40712%

Dr. Kahl compared with the Missouri median for medical oncologists, 2024

  • Dr. Kahl
  • Missouri median
Medicare services
3,395vs 1,2462.7 times
Medicare patients
456vs 2242.0 times
Part D claims
697vs 56024% above

Medians across 125 medical oncologists in Missouri with Dmand AI profiles that report each measure.

Dr. Kahl's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kahl

Need commercial claims for Dr. Kahl?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kahl and other medical oncologists in Missouri.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Brad Steven Kahl treated 456 Medicare patients in 2024, average age 73

CMS counts 456 Medicare patients who saw Dr. Kahl in 2024. The largest group is 65 to 74, with 219 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kahl's median patient age at 73, with 42% women.

Medicare patients, 2024456
Average age73
Average risk score2.48
Also on Medicaid9%

Dr. Kahl's Medicare patients by age, 2024

Dr. Kahl's Medicare patients by sex, 2024

  • Women18541%
  • Men27159%

Chronic conditions among Dr. Kahl's Medicare patients, 2024

  1. High blood pressure73%
  2. High cholesterol70%
  3. Arthritis46%
  4. Chronic kidney disease29%
  5. Ischemic heart disease29%
  6. Anxiety28%
  7. Cancer28%
  8. Diabetes26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Kahl's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women42%
  • Men58%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Brad Steven Kahl wrote 904 Medicare Part D claims in 2024

In 2024, Dr. Kahl wrote 904 Medicare Part D claims for 174 patients. 60% of them were for generic drugs. CMS names the drug for 697 of them, across 19 drugs with 11 or more claims each, at $3,541,355 in total drug cost. In 2023, CMS named 597 claims across 17 drugs.

Part D claims, 2024904
Drugs named by CMS19
Total drug cost$3.5M
Part D patients174

Dr. Kahl's Part D claims by kind of drug, 2024

  • Generic545 claims60%
  • Brand-name359 claims40%

Dr. Kahl's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Kahl's Part D claims, 2024

  • Opioids2%15 of 904 claims
  • Antibiotics4%35 of 904 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 5972024: 69717%

Drugs named by CMS: 19 in 2024, 17 in 2023.

See all prescribing by Dr. Kahl

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Brad Steven Kahl scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Kahl for performance year 2024, reported as part of a group. Dr. Kahl accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Kahl's MIPS scores, performance year 2024

  • 84of 100Final score
  • 71.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 76of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Kahl by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Brad Steven Kahl has 250 publications on record

Dmand AI links 250 papers to Dr. Kahl, published from 2006 to 2025. 2016 was the busiest year, with 19. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Rituximab and Lymphoma, Mantle-Cell. Dr. Kahl has published most often in Leuk Lymphoma. Dr. Kahl's most frequent co-authors are Nancy Lee Bartlett, MD, John P. Leonard, MD and Ranjana Advani, MD.

Papers250
Years published2006 to 2025

Dr. Kahl's papers by year, 2016 to 2025

Topics Dr. Kahl writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Rituximab
  • Lymphoma, Mantle-Cell
  • Vincristine
  • Cyclophosphamide
  • Doxorubicin
  • Lymphoma, Follicular
  • Lymphoma, Large B-Cell, Diffuse

Dr. Kahl's most frequent co-authors

Recent publications by Dr. Kahl

See all 250 publications and co-authors

See who Dr. Kahl researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kahl works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Brad Steven Kahl has worked on 18 clinical trials

Dmand AI links Dr. Kahl to 18 clinical trials, 11 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell and Lymphoma, Follicular. University of Wisconsin, Madison sponsors the most, 5.

Clinical trials with Dr. Kahl by phase

  1. 3Phase 1: 3 trials
  2. 11Phase 2: 11 trials
  3. 1Phase 3: 1 trial
  4. NonePhase 4: no trials

Conditions in Dr. Kahl's trials

  • Lymphoma, Non-Hodgkin
  • Lymphoma, Mantle-Cell
  • Lymphoma, Follicular
  • Lymphoma
  • Lymphoma, B-Cell, Marginal Zone

Investigators on the most trials with Dr. Kahl

Recent clinical trials with Dr. Kahl

See all 18 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Brad Steven Kahl received $420,019 in industry payments from 2016 to 2025

CMS Open Payments shows 349 general payments to Dr. Kahl from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Genentech, Inc. paid the most, $99,132. It also lists 19 research payments totaling $14,147 from 2016 to 2024.

General payments to Dr. Kahl by program year, 2016 to 2025

General payments to Dr. Kahl by kind, 2016 to 2025

$420Kin total
  • Consulting fees$346,53783%
  • Travel and lodging$39,1309%
  • Speaker and faculty fees$13,4393%
  • Honoraria$13,1703%
  • Other$7,7432%

Companies that paid Dr. Kahl the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Kahl

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Brad Steven Kahl has 2 awards and honors on record

Dmand AI lists 2 awards for Dr. Kahl, most recently Regional Top Doctor in 2014.

Awards and honors for Dr. Kahl

  1. 2014
    • Regional Top Doctor
  2. 2011
    • CMS Stage 1 EHR

Source: Dmand AI Professional Profile Data

Dr. Brad Steven Kahl graduated from Tufts University School Of Medicine

Dr. Kahl graduated from Tufts University School Of Medicine in 1994. Dr. Kahl is a member of ASCO.

  1. Medical schoolTufts University School Of Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Brad Steven Kahl accepts plans from 13 insurance carriers

Dr. Kahl is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.

Plan types Dr. Kahl accepts, by number of carriers

  1. PPO10
  2. Medicare9
  3. HMO4
  4. POS3
  5. EPO2
  6. Medicaid2

Source: Dmand AI Insurance Network Data

Sources for Dr. Brad Steven Kahl's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Brad Steven Kahl

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Brad Steven Kahl's NPI number?

Dr. Brad Steven Kahl's NPI number is 1407822430. It was assigned on February 28, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Brad Steven Kahl?

Dr. Brad Steven Kahl is a medical oncologist in Saint Louis, Missouri. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Brad Steven Kahl practice?

Dr. Kahl practices at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110. Dr. Kahl also practices at 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110. Dr. Kahl's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dmand AI also links Dr. Kahl to 3 hospitals and 1 group practice or clinic.

What is Dr. Brad Steven Kahl's office phone number?

The practice phone on file for Dr. Kahl is (314) 747-3000.

What is Dr. Brad Steven Kahl's medical license number?

Dr. Kahl holds Missouri license 2015029481, one of the licenses on file in 3 states.

Which states has Dr. Brad Steven Kahl been licensed in?

Dmand AI has state licenses on file for Dr. Kahl in Missouri (2015 to 2026), Illinois (2020 to 2023) and Wisconsin (1995 to 2015).

Which hospitals is Dr. Brad Steven Kahl affiliated with?

Dr. Kahl practices at Barnes-Jewish Hospital in Saint Louis, Missouri. Dr. Kahl is also affiliated with Missouri Baptist Medical Center. Dmand AI links Dr. Kahl to 3 more hospitals.

What medical group is Dr. Brad Steven Kahl part of?

Dr. Kahl is linked to WashU Medicine Psychiatry.

Does Dr. Brad Steven Kahl accept Medicare?

Yes. CMS data shows Dr. Kahl billed Medicare for 3,395 services in 2024, and Dr. Kahl accepts Medicare assignment.

What is Dr. Brad Steven Kahl's MIPS score?

Dr. Kahl's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Brad Steven Kahl see?

CMS counts 456 Medicare patients who saw Dr. Kahl in 2024, with an average age of 73.

Is Dr. Brad Steven Kahl board certified?

Yes. Dr. Kahl is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Brad Steven Kahl bill to Medicare?

In 2024, Dr. Kahl's most billed Medicare services were injected or infused drug (J1561), injected or infused drug (J1100) and hospital inpatient care (99232).

Where did Dr. Brad Steven Kahl go to medical school?

Dr. Kahl graduated from Tufts University School Of Medicine in 1994.

What drugs does Dr. Brad Steven Kahl prescribe most?

In 2024 Medicare Part D data, Dr. Kahl's most prescribed drugs by claims were Brukinsa, Acyclovir and Prochlorperazine Maleate.

Has Dr. Brad Steven Kahl received payments from drug or device companies?

CMS Open Payments shows $420,019 in general payments to Dr. Kahl from 27 companies from 2016 to 2025. The largest total came from Genentech, Inc.

How long has Dr. Brad Steven Kahl been practicing?

Dr. Kahl graduated from medical school in 1994, 32 years ago.

Does Dr. Brad Steven Kahl do research?

Dmand AI links 250 publications to Dr. Kahl, published from 2006 to 2025. Dr. Kahl has worked on 18 clinical trials.

Who does Dr. Brad Steven Kahl publish with?

Dr. Kahl's most frequent co-authors are Nancy Lee Bartlett, MD (35 shared papers), John P. Leonard, MD (35 shared papers) and Ranjana Advani, MD (23 shared papers).

What insurance does Dr. Brad Steven Kahl accept?

Dr. Kahl is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Missouri by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)